Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-275
Closed -$76.8K 154
2025
Q2
$76.8K Hold
275
0.01% 189
2025
Q1
$85.7K Buy
275
+1
+0.4% +$295 0.02% 185
2024
Q4
$71.4K Buy
+274
New +$81.3K 0.01% 202
2023
Q2
Sell
-115
Closed -$27.8K 102
2023
Q1
$27.8K Buy
115
+19
+20% +$4.66K 0.01% 222
2022
Q4
$25.2K Buy
96
+11
+13% +$2.95K 0.01% 232
2022
Q3
$19K Buy
85
+1
+1% +$242 0.01% 221
2022
Q2
$20K Buy
84
+9
+12% +$2.21K 0.01% 213
2022
Q1
$18K Hold
75
0.01% 265
2021
Q4
$16K Sell
75
-23
-23% -$4.85K 0.01% 290
2021
Q3
$20K Buy
98
+19
+24% +$4.37K 0.01% 246
2021
Q2
$19K Hold
79
0.01% 224
2021
Q1
$19K Hold
79
0.01% 203
2020
Q4
$18K Buy
+79
New +$18.2K 0.01% 202

Other funds holding AMGN

Bellwether Advisors's AMGN Position: Q3 2025 in Review

Bellwether Advisors sold out of Amgen (AMGN) in Q3 2025, closing a stake of 275 shares — an estimated $76.8K sold.

Bellwether Advisors first reported a position in AMGN in Q4 2020 and held it in 13 quarters. The position peaked at $85.7K in Q1 2025. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Bellwether Advisors reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Bellwether Advisors sold 275 Amgen shares in Q3 2025, an estimated $76.8K.
  • Bellwether Advisors first reported a position in Amgen in Q4 2020 and held it in 13 quarters.
  • Bellwether Advisors's Amgen position peaked at $85.7K in Q1 2025.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Bellwether Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.